Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

MLA

Annelies Van Hemelryk, et al. “Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.” Cells, vol. 12, no. 10, May 2023, p. 1377. EBSCOhost, https://doi.org/10.3390/cells12101377.

APA

Annelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, Corrina M. A. de Ridder, Debra C. Stuurman, Guido W. Jenster, Martin E. van Royen, & Wytske M. van Weerden. (2023). Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. Cells, 12(10), 1377. https://doi.org/10.3390/cells12101377

Chicago

Annelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, Corrina M. A. de Ridder, Debra C. Stuurman, Guido W. Jenster, Martin E. van Royen, and Wytske M. van Weerden. 2023. “Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.” Cells 12 (10): 1377. doi:10.3390/cells12101377.